DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Froissart A, Buffet M, Veyradier A. et al; French Thrombotic Microangiopathies Reference Center, Experience of the French Thrombotic Microangiopathies Reference Center.
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange.
Crit Care Med 2012;
40 (01) 104-111
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.